Open Access
BIO Web Conf.
Volume 59, 2023
2023 5th International Conference on Biotechnology and Biomedicine (ICBB 2023)
Article Number 02006
Number of page(s) 10
Section Precision Medicine and Drug Development and Preparation
Published online 08 May 2023
  • Baxter, A. J., Scott, K. M., Vos, T., & Whiteford, H. A. (2012, July 10). Global prevalence of Anxiety Disorders: A systematic review and meta-regression: Psychological medicine. Cambridge Core. Retrieved August 6, 2022, from [Google Scholar]
  • Meier, S. M., Mattheisen, M., Mors, O., Mortensen, P. B., Laursen, T. M., & Penninx, B. W. (2016). Increased mortality among people with anxiety disorders: total population study. The British journal of psychiatry : the journal of mental science, 209(3), 216–221. [PubMed] [Google Scholar]
  • Madonna, D., Delvecchio, G., Soares, J. C., & Brambilla, P. (2019). Structural and functional neuroimaging studies in generalized anxiety disorder: a systematic review. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 41(4), 336–362. and meta-regression: Psychological medicine. Cambridge Core. Retrieved August 6, 2022, from [CrossRef] [PubMed] [Google Scholar]
  • Sun, X., Ming, Q., Zhong, X., Dong, D., Li, C., Xiong, G., Cheng, C., Cao, W., He, J., Wang, X., Yi, J., & Yao, S. (2020, May 15). The Maoa gene influences the neural response to psychosocial stress in the human brain. Frontiers. Retrieved August 7, 2022, from [Google Scholar]
  • Gottschalk, M. G., & Domschke, K. (2017). Genetics of generalized anxiety disorder and related traits. Dialogues in clinical neuroscience, 19(2), 159–168. [CrossRef] [PubMed] [Google Scholar]
  • Taylor S. (2020). Anxiety disorders, climate change, and the challenges ahead: Introduction to the special issue. Journal of anxiety disorders, 76, 102313. [CrossRef] [PubMed] [Google Scholar]
  • Clayton S. (2020). Climate anxiety: Psychological responses to climate change. Journal of anxiety disorders, 74, 102263. [CrossRef] [PubMed] [Google Scholar]
  • Kascakova, N., Furstova, J., Hasto, J., Madarasova Geckova, A., & Tavel, P. (2020). The Unholy Trinity: Childhood Trauma, Adulthood Anxiety, and LongTerm Pain. International journal of environmental research and public health, 17(2), 414. [CrossRef] [PubMed] [Google Scholar]
  • Kuzminskaite, E., Penninx, B., van Harmelen, A. L., Elzinga, B. M., Hovens, J., & Vinkers, C. H. (2021). Childhood Trauma in Adult Depressive and Anxiety Disorders: An Integrated Review on Psychological and Biological Mechanisms in the NESDA Cohort. Journal of affective disorders, 283, 179–191. [CrossRef] [PubMed] [Google Scholar]
  • Xu, P., Chen, A., Li, Y., Xing, X., & Lu, H. (2019). Medial prefrontal cortex in neurological diseases. Physiological genomics, 51(9), 432–442. [CrossRef] [PubMed] [Google Scholar]
  • Gibson-Smith, D., Bot, M., Brouwer, I. A., Visser, M., Giltay, E. J., & Penninx, B. (2020). Association of food groups with depression and anxiety disorders. European journal of nutrition, 59(2), 767–778. [CrossRef] [PubMed] [Google Scholar]
  • Meier, S. M., Trontti, K., Purves, K. L., Als, T. D., Grove, J., Laine, M., Pedersen, M. G., Bybjerg-Grauholm, J., Bækved-Hansen, M., Sokolowska, E., Mortensen, P. B., Hougaard, D. M., Werge, T., Nordentoft, M., Breen, G., Børglum, A. D., Eley, T. C., Hovatta, I., Mattheisen, M., & Mors, O. (2019). Genetic Variants Associated With Anxiety and Stress-Related Disorders: A Genome-Wide Association Study and Mouse-Model Study. JAMA psychiatry, 76(9), 924–932. [CrossRef] [PubMed] [Google Scholar]
  • Chubar, V., Van Leeuwen, K., Bijttebier, P., Van Assche, E., Bosmans, G., Van den Noortgate, W., van Winkel, R., Goossens, L., & Claes, S. (2020). Gene-environment interaction: New insights into perceived parenting and social anxiety among adolescents. European psychiatry : the journal of the Association of European Psychiatrists, 63(1), e64. [CrossRef] [PubMed] [Google Scholar]
  • Sutton, Laurie, et al. “Orphan Receptor GPR158 Controls Stress-induced Depression.” eLife, 8 Feb. 2018, [PubMed] [Google Scholar]
  • Yan, Hai-Liang, et al. “Mir-137 Deficiency Causes Anxiety-like Behaviors in Mice.” Frontiers, Frontiers, 11 Oct. 2019, [Google Scholar]
  • Bhandari, Tamara. “Immune System Affects Mind and Body, Study Indicates.” Washington University School of Medicine in St. Louis, 25 May 2022, [Google Scholar]
  • Chand S.P., Kuckel D.P., Huecker M.R. Cognitive Behavior Therapy. [Updated 2022 May 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. [Google Scholar]
  • van Dis, E., van Veen, S. C., Hagenaars, M. A., Batelaan, N. M., Bockting, C., van den Heuvel, R. M., Cuijpers, P., & Engelhard, I. M. (2020). Long-term Outcomes of Cognitive Behavioral Therapy for Anxiety-Related Disorders: A Systematic Review and Meta-analysis. JAMA psychiatry, 77(3), 265–273. [CrossRef] [PubMed] [Google Scholar]
  • James, A. C., Reardon, T., Soler, A., James, G., & Creswell, C. (2020). Cognitive behavioural therapy for anxiety disorders in children and adolescents. The Cochrane database of systematic reviews, 11(11), CD013162. [PubMed] [Google Scholar]
  • Rozenman, M., Piacentini, J., O'Neill, J., Bergman, R. L., Chang, S., & Peris, T. S. (2019). Improvement in anxiety and depression symptoms following cognitive behavior therapy for pediatric obsessive compulsive disorder. Psychiatry research, 276, 115–123. [CrossRef] [PubMed] [Google Scholar]
  • Ghahari, S., Mohammadi-Hasel, K., Malakouti, S. K., & Roshanpajouh, M. (2020). Mindfulness-based Cognitive Therapy for Generalised Anxiety Disorder: a Systematic Review and Meta-analysis. East Asian archives of psychiatry: official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan, 30(2), 52–56. [Google Scholar]
  • Health Quality Ontario (2019). Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment. Ontario health technology assessment series, 19(6), 1–199. [Google Scholar]
  • Nordh, M., Wahlund, T., Jolstedt, M., Sahlin, H., Bjureberg, J., Ahlen, J., Lalouni, M., Salomonsson, S., Vigerland, S., Lavner, M., Öst, L. G., Lenhard, F., Hesser, H., Mataix-Cols, D., Högström, J., & Serlachius, E. (2021). Therapist-Guided Internet-Delivered Cognitive Behavioral Therapy vs Internet-Delivered Supportive Therapy for Children and Adolescents With Social Anxiety Disorder: A Randomized Clinical Trial. JAMA psychiatry, 78(7), 705–713. [CrossRef] [PubMed] [Google Scholar]
  • Romijn, G., Batelaan, N., Kok, R., Koning, J., van Balkom, A., Titov, N., & Riper, H. (2019). Internet-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Open Community Versus Clinical Service Recruitment: Meta-Analysis. Journal of medical Internet research, 21(4), e11706. [CrossRef] [PubMed] [Google Scholar]
  • Authors, A., & Cassano, G. B. (2022, April 1). Psychopharmacology of Anxiety Disorders. Taylor & Francis. Retrieved August 6, 2022, from [Google Scholar]
  • MediLexicon International. (2020, October 23). SSRI vs SNRI: Differences, how they work, and side effects. Medical News Today. Retrieved August 6, 2022, from [Google Scholar]
  • Strawn, J. R., Geracioti, L., Rajdev, N., Clemenza, K., & Levine, A. (2018). Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review. Expert opinion on pharmacotherapy, 19(10), 1057–1070. [CrossRef] [PubMed] [Google Scholar]
  • Ferreira-Garcia, R., de Costa, M.A., Gonçalves, F. G., de Nonohay, R. G., Nardi, A. E., da Freire, R. C. R., & Manfro, G. G. (2021, September 2). Heart rate variability: A biomarker of selective response to mindfulness-based treatment versus fluoxetine in generalized anxiety disorder. Journal of Affective Disorders. Retrieved August 6, 2022, from [Google Scholar]
  • Costa, M. A., Gonçalves, F. G., Tatton-Ramos, T., Fonseca, N. K. O., Schwinn, J. K., Alves, S. G., Salum, G. A., & Manfro, G. G. (2020, December 15). A three-arm randomized clinical trial comparing the efficacy of a mindfulness-based intervention with an active comparison group and fluoxetine treatment for adults with generalized anxiety disorder. Psychotherapy and Psychosomatics. Retrieved August 6, 2022, from [Google Scholar]
  • Tini, E., Smigielski, L., Romanos, M., Wewetzer, C., Karwautz, A., Reitzle, K., Correll, C. U., Plener, P. L., Malzahn, U., Heuschmann, P., Unterecker, S., Scherf-Clavel, M., Rock, H., Antony, G., Briegel, W., Fleischhaker, C., Banaschewski, T., Hellenschmidt, T., & Walitza, S. (2022, February 26). Therapeutic drug monitoring of sertraline in children and adolescents: A naturalistic study with insights into the clinical response and treatment of obsessivecompulsive disorder. Comprehensive Psychiatry. Retrieved August 6, 2022, from [Google Scholar]
  • Li, Xinyuan et al. “Efficacy and tolerability of paroxetine in adults with social anxiety disorder: A meta-analysis of randomized controlled trials.” Medicine vol. 99, 14 (2020): e19573. doi: 10.1097/MD.0000000000019573 [CrossRef] [PubMed] [Google Scholar]
  • Kong, W., Deng, H., Wan, J., Zhou, Y., Zhou, Y., Song, B., & Wang, X. (2020). Comparative Remission Rates and Tolerability of Drugs for Generalised Anxiety Disorder: A Systematic Review and Network Meta-analysis of Double-Blind Randomized Controlled Trials. Frontiers in pharmacology, 11, 580858. [CrossRef] [PubMed] [Google Scholar]
  • Rodrigues-Amorim, D., Olivares, J. M., Spuch, C., & Rivera-Baltanas, T. (2020). A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine. Frontiers in psychiatry, 11, 554899. [CrossRef] [PubMed] [Google Scholar]
  • Carton, L., Niot, C., Kyheng, M., Petrault, M., Laloux, C., Potey, C., Lenski, M., Bordet, R., & Deguil, J. (2021, December 3). Lack of direct involvement of a diazepam long-term treatment in the occurrence of irreversible cognitive impairment: A pre-clinical approach. Nature News. Retrieved August 6, 2022, from [Google Scholar]
  • Piwowarczyk-Nowak, A., Palasz, A., Bogus, K., Krzystanek, M., Blaszczyk, I., Worthington, J. J., & Grajoszek, A. (2022, June 11). Modulatory effect of long-term treatment with escitalopram and clonazepam on the expression of anxiety-related neuropeptides: Neuromedin u, neuropeptide S and their receptors in the rat brain - molecular biology reports. SpringerLink. Retrieved August 6, 2022, from [Google Scholar]
  • Vicente, B., Saldivia, S., Hormazabal, N., Bustos, C., & Rubí, P. (2020, October 2). Etifoxine is noninferior than clonazepam for reduction of anxiety symptoms in the treatment of anxiety disorders: A randomized, double blind, non-inferiority trial - psychopharmacology. SpringerLink. Retrieved [Google Scholar]
  • Wolyńczyk-Gmaj, Dorota et al. “Can Dog-Assisted Intervention Decrease Anxiety Level and Autonomic Agitation in Patients with Anxiety Disorders?.” Journal of clinical medicine vol. 10, 21 5171. 4 Nov. 2021, doi: 10.3390/jcm10215171 [CrossRef] [PubMed] [Google Scholar]
  • Melas P.A.; Scherma, M.; Fratta, W.; Cifani, C.; Fadda, P.; “Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research.” International Journal of Molecular Sciences, U.S. National Library of Medicine, 13 Feb. 2021, [PubMed] [Google Scholar]
  • Sartori, Simone B., and Nicolas Singewald. “Novel Pharmacological Targets in Drug Development for the Treatment of Anxiety and Anxiety-related Disorders.” Pharmacology &Amp; Therapeutics, vol. 204, Elsevier BV, Dec. 2019, p. 107402. [CrossRef] [PubMed] [Google Scholar]
  • Murrough, James W., et al. “Emerging Drugs for the Treatment of Anxiety.” Expert Opinion on Emerging Drugs, vol. 20, no. 3, Informa Healthcare, May 2015, pp. 393–406. [CrossRef] [PubMed] [Google Scholar]
  • Gupta, Priti Ramakant, and Kedar Prabhavalkar. “Combination Therapy With Neuropeptides for the Treatment of Anxiety Disorder.” Neuropeptides, vol. 86, Elsevier BV, Apr. 2021, p. 102127. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.